Interleukin-2 receptor antagonist immunosuppression and consecutive viral management in living-donor liver transplantation for human immunodeficiency virus/hepatitis C-co-infected patients: a report of 2 cases-Reference-Cited by-同舟云学术

Interleukin-2 receptor antagonist immunosuppression and consecutive viral management in living-donor liver transplantation for human immunodeficiency virus/hepatitis C-co-infected patients: a report of 2 cases

Published:2015-12-12 Issue:1 Volume:9 Page:32-37
ISSN:1865-7257
Container-title:Clinical Journal of Gastroenterology
language:en
Short-container-title:Clin J Gastroenterol

Author:

Maki Harufumi,Kaneko Junichi,Akamatsu Nobuhisa,Arita Junichi,Sakamoto Yoshihiro,Hasegawa Kiyoshi,Tanaka Tomohiro,Tamura Sumihito,Sugawara Yasuhiko,Tsukada Kunihisa,Kokudo Norihiro

Funder

Ministry of Education, Culture, Sports, Science, and Technology of Japan

Ministry of Health, Labour and Welfare

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12328-015-0621-8.pdf

Reference16 articles.

1. Koike K, Tsukada K, Yotsuyanagi H, et al. Prevalence of coinfection with human immunodeficiency virus and hepatitis C virus in Japan. Hepatol Res. 2007;37(1):2–5.

2. Miro JM, Stock P, Teicher E, Duclos-Vallee JC, Terrault N, Rimola A. Outcome and management of HCV/HIV coinfection pre- and post-liver transplantation. A 2015 update. J Hepatol. 2015;62(3):701–11.